Development of an Allogeneic Universally Tolerated NKT Cell Platform for Off-the-Shelf Cancer Immunotherapy

被引：0
|
作者：
Jin, Jingling [1 ]
Liu, Bin [1 ]
Guo, Linjie [1 ]
Di Pierro, Erica J. [1 ]
Balzeau, Julien [1 ]
Courtney, Amy [1 ]
Ngai, Ho [1 ]
Metelitsa, Leonid S. [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
MOLECULAR THERAPY | 2019年 / 27卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
682
引用
收藏
页码：321 / 321
页数：1
相关论文
共 50 条
  • [21] T-Cell Engineering For "off-The-shelf" Adoptive Immunotherapy
    Poirot, Laurent
    Schiffer-Mannioui, Cecile
    Philip, Brian
    Derniame, Sophie
    Gouble, Agnes
    Chion-Sotinel, Isabelle
    Le Clerre, Diane
    Lemaire, Laetitia
    Grosse, Stephanie
    Cheung, Gordon
    Arnould, Sylvain
    Smith, Julianne
    Pule, Martin
    Scharenberg, Andrew
    BLOOD, 2013, 122 (21)
  • [22] T-cell engineering for "off-the-shelf" adoptive immunotherapy
    Poirot, L.
    Mannioui, C. Schiffer
    Philips, B.
    Derniame, S.
    Gouble, A.
    Chion-Sotinel, I.
    Le Clerre, D.
    Lemaire, L.
    Grosse, S.
    Cheung, G.
    Arnould, S.
    Smith, J.
    Pule, M.
    Scharenberg, A.
    HUMAN GENE THERAPY, 2013, 24 (12) : A45 - A45
  • [23] Off-the-Shelf CAR-NK Cells for Cancer Immunotherapy
    Siegler, Elizabeth L.
    Zhu, Yanni
    Wang, Pin
    Yang, Lili
    CELL STEM CELL, 2018, 23 (02) : 160 - 161
  • [24] In situ vaccination: Cancer immunotherapy both personalized and off-the-shelf
    Hammerich, Linda
    Binder, Adam
    Brody, Joshua D.
    MOLECULAR ONCOLOGY, 2015, 9 (10) : 1966 - 1981
  • [25] Generation of an off-the-shelf cell-based platform (PDC-vac) for active antitumor immunotherapy
    Plumas, Joel
    Lenogue, Kevin
    Walencik, Alexandre
    Molens, Jean-Paul
    Chaperot, Laurence
    Pule, Martin
    CANCER RESEARCH, 2017, 77
  • [26] Optimal, Off-the-Shelf, CAR-iNKT Cell Platform-Based Immunotherapy for Multiple Myeloma
    Ponnusamy, Kanagaraju
    Randzavola, Lyra
    Ren, Hongwei
    Karaxhuku, Klesti
    Lye, Bryan
    Leonardos, Dimitrios
    Nadafi, Reza
    Sarkar, Irene
    Leontari, Ilia
    Sabrin, Farah
    Zaidi, Mehmood
    Bua, Marco
    Atta, Maria
    Katsarou, Alexia
    Roberts, Irene
    Chaidos, Aristeidis
    Karadimitris, Anastasios
    BLOOD, 2023, 142
  • [27] Generation of Off-the-Shelf Allogeneic Hypoimmune Tregs
    Gyurova, Ivayla E.
    Yu, John
    Hu, Xiaomeng
    Chu, Elaine Y.
    Young, Chi
    Schrepfer, Sonja
    MOLECULAR THERAPY, 2022, 30 (04) : 587 - 588
  • [28] COMPREHENSIVE ACTIVATION PROFILING OF TABELECLEUCEL, AN OFF-THE-SHELF, ALLOGENEIC EBV-SPECIFIC T-CELL IMMUNOTHERAPY
    Ruiz, F.
    Jehng, T.
    Spindler, T.
    Munson, D. J.
    Karlen, J.
    Thota, V.
    Wang, A.
    Chuan, J.
    Yedwabnick, M.
    Dubovksy, J.
    Aftab, B. T.
    CYTOTHERAPY, 2021, 23 (05) : S160 - S160
  • [29] Clinical Translation of Pluripotent Cell-Derived Off-the-Shelf Natural Killer Cell Cancer Immunotherapy
    Cichocki, Frank
    Bjordahl, Ryan
    Gaidarova, Svetlana
    Rogers, Paul
    Clarke, Raedun
    Groff, Brian
    Moreno, Stacey
    Abujarour, Ramzey
    Robinson, Megan
    Bonello, Greg
    Lee, Tom
    Lan, Weijie
    Rezner, Betsy
    Abbot, Stewart
    Sumstad, Darin
    Blazar, Bruce
    Shoemaker, Daniel
    Wolchko, Scott
    Kaufman, Dan
    McKenna, David H.
    Valamehr, Bahram
    Cooley, Sarah
    Miller, Jeffrey S.
    BLOOD, 2017, 130
  • [30] “Off-the-Shelf” Allogeneic CAR Cell Therapy—Neglected HvG Effect
    Yuxin An
    Xin Jin
    Hongkai Zhang
    Meng Zhang
    Sadhana Mahara
    Wenyi Lu
    Mingfeng Zhao
    Current Treatment Options in Oncology, 2023, 24 : 409 - 441
12345